Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrow

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Scientific Reports|November 13, 2019
Binding and structural analyses of potent inhibitors of the human Ca<sup>2+</sup>/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitorsGerson S Profeta, Caio V Dos Reis, André da S Santiago, et al.
Current Research in Chemical Biology|November 27, 2023
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4Deanna Tiek, Carrow I Wells, Martin Schröder, et al.
Blood|September 15, 2025
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myelomaZhibo Yan, Zhannan Han, Yihui Wang, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Xuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Nature Communications|June 4, 2020
Quantifying CDK inhibitor selectivity in live cellsCarrow I Wells, James D Vasta, Cesear R Corona, et al.
ACS Chemical Biology|June 20, 2022
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-CoronavirusesXuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 25, 2025
Protein-Like Polymers Targeting Keap1/Nrf2 as Therapeutics for Myocardial InfarctionJoshua M Mesfin, Kendal P Carrow, Alexander Chen, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Science Advances|June 22, 2022
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomasDeanna M Tiek, Beril Erdogdu, Roham Razaghi, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2KCarrow Wells, Rafael M Couñago, Juanita C Limas, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Scientific Reports|November 13, 2019
Binding and structural analyses of potent inhibitors of the human Ca<sup>2+</sup>/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitorsGerson S Profeta, Caio V Dos Reis, André da S Santiago, et al.
Current Research in Chemical Biology|November 27, 2023
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4Deanna Tiek, Carrow I Wells, Martin Schröder, et al.
Blood|September 15, 2025
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myelomaZhibo Yan, Zhannan Han, Yihui Wang, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Xuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Nature Communications|June 4, 2020
Quantifying CDK inhibitor selectivity in live cellsCarrow I Wells, James D Vasta, Cesear R Corona, et al.
ACS Chemical Biology|June 20, 2022
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-CoronavirusesXuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 25, 2025
Protein-Like Polymers Targeting Keap1/Nrf2 as Therapeutics for Myocardial InfarctionJoshua M Mesfin, Kendal P Carrow, Alexander Chen, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Science Advances|June 22, 2022
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomasDeanna M Tiek, Beril Erdogdu, Roham Razaghi, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2KCarrow Wells, Rafael M Couñago, Juanita C Limas, et al.
Pageof 18